Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles

• Asıl Yazarlar: Jochen H.O. Hoffmann (Yazar), Christian Knoop (Yazar), Knut Schäkel (Yazar), Alexander H. Enk (Yazar), Eva N. Hadaschik (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Medical Journals Sweden, 2021-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The efficacy of psoriasis treatments is usually evaluated using the Psoriasis Area and Severity Index (PASI). However, there is a lack of systematic statistical assessments of PASI as a proxy for systemic disease in individual patients. Therefore, a retrospective study of 186 treat­ments with adalim...